99008-87-4 Usage
Functional Groups
Diethylamino group: Provides basic properties, influencing solubility and reactivity.
Nitro group: Can enhance electron density, affecting reactivity and potentially bioactivity.
Ester functional group: Imparts ester-like properties, such as stability and hydrolysis susceptibility.
Structural Feature
Pyrazolo[3,4,5-kl]acridine ring: A fused bicyclic heterocyclic ring system, contributing to the compound's aromaticity and overall structure.
Attached Moiety
2,2-dimethylpropanoate: Adds steric hindrance and potentially alters the compound's lipophilicity and stability.
Potential Applications
Pharmaceutical or research applications: Due to its complex structure, it could serve as a precursor or intermediate in the synthesis of various chemicals or materials.
Reactivity
Reactivity would depend on the nature of the functional groups and their positioning within the molecule, influencing potential chemical reactions and applications.
Solubility
Solubility characteristics can vary based on the presence of polar or nonpolar groups, impacting its use in different solvents or formulations.
Check Digit Verification of cas no
The CAS Registry Mumber 99008-87-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,9,0,0 and 8 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 99008-87:
(7*9)+(6*9)+(5*0)+(4*0)+(3*8)+(2*8)+(1*7)=164
164 % 10 = 4
So 99008-87-4 is a valid CAS Registry Number.
99008-87-4Relevant articles and documents
2-(Aminoalkyl)-5-nitropyrazoloacridines, a New Class of Anticancer Agents
Capps, David B.,Dunbar, James,Kesten, Suzanne R.,Shillis, Joan,Werbel, Leslie M.,et al.
, p. 4770 - 4778 (2007/10/02)
2-(Aminoalkyl)-5-nitropyrazoloacridines were prepared from substituted anilines via the 1-chloro-4-nitroacridones followed by condensation with hydrazines.Impressive activity was demonstrated for the 9-hydroxy, 9-alkoxy, and 9-acyloxy analogs in vitro on a L1210 leukemia line and in vivo against the P388 leukemia.Advanced studies led to the selection of 3bbb for clinical trial.